# VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?

> **NCT02918851** · PHASE4 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Transfusion of 7-day stored red blood cells
- **BIOLOGICAL:** Transfusion of 28-day stored red blood cells
- **BIOLOGICAL:** Transfusion of 42-day stored red blood cells

## Key facts

- **NCT ID:** NCT02918851
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2019-08-09
- **Final completion:** 2019-11-20
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918851, "VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02918851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*